Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias

NCT07342413 PHASE4 NOT_YET_RECRUITING

The primary objective is to compare physician-assessed clearance of telangiectatic veins between treatment legs using the Physician Global Aesthetic Improvement Scale (PGAIS). Secondary objectives include assessment of procedural pain, safety outcomes, and patient satisfaction.

Details

Lead sponsor	Goldman, Butterwick, Fitzpatrick and Groff
Phase	PHASE4
Status	NOT_YET_RECRUITING
Enrolment	20
Start date	Sun Feb 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jul 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Leg Veins

Interventions

• Right leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine
• Left leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine

Countries

United States